In pancreatic cancer the expression of merlin was found to be decreased and re-expression inhibited growth of pancreatic cancer by suppressing the Wnt/β-catenin signaling downstream genes, suggesting that targeting β-catenin could be used as effective therapy [228]. This evidence concerns the gene NF2 and familial pancreatic carcinoma.